WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 7101 Infant (under 12 months) mortality rate: 662
GDP / capita (US$): 1'6841 Child (under 5 years) mortality rate: 1022

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 17'420  16'935  16'460  15'995  15'540  11'608  8'811  6'823 
Births 703  693  683  672  662  538  419  336 
Surviving infants 656  645  634  623  612  487  374  294 
Pop. less than 5 years 3'033  2'983  2'932  2'874  2'804  2'172  1'663  1'278 
Pop. less than 15 years 7'890  7'712  7'530  7'343  7'148  5'429  4'163  3'110 
Female 15-49 years 4'046  3'921  3'801  3'687  3'579  2'642  1'959  1'539 

Number of reported case

(Click for retrospective incidence data for Burkina Faso)
Diphtheria 725 
Japanese encephalitis
Measles 343  375  7'362  860  2'511  6'074  9'804  13'713 
Mumps 8'090 
Pertussis 13  351  713  3'888 
Polio* 18  145 
Rubella 57  27  677 
Rubella (CRS)
Tetanus (neonatal) 22  100 
Tetanus (total)** 96  27  74  100  746 
Yellow fever 1'024 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Burkina Faso)
Vaccine year result method % card seen                                                
BCG 2009  97  DHS/MICS   83  98  96  97  99  99  80 
DTP1 2009  94  DHS/MICS   83  95  94  94  93  93  84 
DTP3 2009  90  DHS/MICS   83  91  88  90  91  91  57 
DTP4         
IPV1         
HepB_BD         
HepB3 2009  90  DHS/MICS   83  91  88  90  99*  99* 
Hib3 2009  90  DHS/MICS   83  91  88  90  99*  99* 
JapEnc         
MCV1          88  82  87  63  63  59 
MCV2          17 
PCV1          95  31 
PCV3          91 
Pol3 2009  90  DHS/MICS   83  91  89  90  90  90  57 
Rota1          95  31 
Rota_last          91 
Rubella1         
TT2plus 2009  71  DHS/MICS   83  91  71  86  82  82 
PAB         
VAD1          99*  99* 
YFV 2008  94  EPI   96  88  99*  87  82  82  56  65 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Burkina Faso)
BCG 98  96  96  99  99  81  95 
DTP1 95  94  94  93  93  97  92 
DTP3 91  88  90  91  91  45  66 
HepB3 91  88  90  91  91 
HepB_BD
Hib3 91  88  90  91  91 
MCV1 88  82  87  89  92  48  79 
MCV2 17 
PAB 89  88  88  88  85  57  55 
PCV3 91 
Pol3 91  89  90  90  90  45  66 
Rota_last 91 
YFV 87  87  87  82  82  40 

Number of districts in the country 63  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 94
From 80 to 89% 6
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 8, 12, 16 weeks; Yes
HPV 9 years; +1 month; No From October 2015
IPV 4 months; Yes From October 2015
MR 9, 15 months; Yes From April 2015
Measles 9, 15 months; Yes
OPV birth; 8, 12, 16 weeks; Yes
Pneumo_conj 8, 12, 16 weeks; Yes
Rotavirus 8, 12, 16 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +2 years; Yes pregnant women
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 63  63  63  63  63  63  63 

System performance

Total Nº districts in country number 63  63  63  63  63  63  63 
Nº districts with DTP3 coverage >=80% number 63  63  63  62  63  63  62 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  98  100  100  98 
Nº districts with measles (MCV1) coverage >=95% number 46  48  46  43  39  36  49 
% of districts with MCV1 coverage >=95% From 0 to 100% 73  76  73  68  62  57  78 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 22    33  34    69 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.